FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emmanuel Canet

Research Profile

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Emmanuel Canet; Guy Lerebours; Jean-Paul Vilaine
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
Valérie Audinot; Nelly Fabry; Jean-Paul Nicolas; Philippe Beauverger; Adrian Newman-Tancredi; Mark J Millan; Anne Try; Frédéric Bornancin; Emmanuel Canet; Jean A Boutin
Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.
Thomas Suply; Odile Della Zuana; Valérie Audinot; Marianne Rodriguez; Philippe Beauverger; Jacques Duhault; Emmanuel Canet; Jean-Pierre Galizzi; Jean-Louis Nahon; Nigel Levens; Jean A Boutin
SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emmanuel Canet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Emmanuel Canet; Guy Lerebours; Jean-Paul Vilaine
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
Annals of the New York Academy of Sciences 2011;1222():90-9.
2002: Valérie Audinot; Nelly Fabry; Jean-Paul Nicolas; Philippe Beauverger; Adrian Newman-Tancredi; Mark J Millan; Anne Try; Frédéric Bornancin; Emmanuel Canet; Jean A Boutin
Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.
Cellular signalling 2002;14(10):829-37.
2001: Thomas Suply; Odile Della Zuana; Valérie Audinot; Marianne Rodriguez; Philippe Beauverger; Jacques Duhault; Emmanuel Canet; Jean-Pierre Galizzi; Jean-Louis Nahon; Nigel Levens; Jean A Boutin
SLC-1 receptor mediates effect of melanin-concentrating hormone on feeding behavior in rat: a structure-activity study.
The Journal of pharmacology and experimental therapeutics 2001;299(1):137-46.
2001: Michel Feletou; Michel Lonchampt; F Coge; Jean-Pierre Galizzi; C Bassoullet; C Merial; P Robineau; Jean A Boutin; P L Huang; Paul M Vanhoutte; Emmanuel Canet
Regulation of murine airway responsiveness by endothelial nitric oxide synthase.
American journal of physiology. Lung cellular and molecular physiology 2001;281(1):L258-67.
2001: Olivier Nosjean; J P Nicolas; F Klupsch; Philippe Delagrange; Emmanuel Canet; Jean A Boutin
Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 .
Biochemical pharmacology 2001;61(11):1369-79.
2001: Valérie Audinot; Philippe Beauverger; Chantal Lahaye; Thomas Suply; Marianne Rodriguez; C Ouvry; Véronique Lamamy; Jérôme Imbert; Herve RIQUE; Jean-Louis Nahon; Jean-Pierre Galizzi; Emmanuel Canet; Nigel Levens; JL Fauchere; Jean A Boutin
Structure-activity relationship studies of melanin-concentrating hormone (MCH)-related peptide ligands at SLC-1, the human MCH receptor.
The Journal of biological chemistry 2001;276(17):13554-62.
2001: Gilles Ferry; V Bruneau; Philippe Beauverger; M Goussard; Marianne Rodriguez; Véronique Lamamy; Sandra Dromaint; Emmanuel Canet; Jean-Pierre Galizzi; Jean A Boutin
Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands.
European journal of pharmacology 2001;417(1-2):77-89.
2000: Olivier Nosjean; M Ferro; F Coge; Philippe Beauverger; JM Henlin; François Lefoulon; JL Fauchere; Philippe Delagrange; Emmanuel Canet; Jean A Boutin
Identification of the melatonin-binding site MT3 as the quinone reductase 2.
The Journal of biological chemistry 2000;275(40):31311-7.
2000: I Deprez-Roy; F Coge; L Bertry; Jean-Pierre Galizzi; Michel Feletou; Paul M Vanhoutte; Emmanuel Canet
Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells.
Acta pharmacologica Sinica 2000;21(6):499-506.
2000: Gilles Ferry; Armelle Loynel; Nathalie Kucharczyk; Sophie Bertin; Marianne Rodriguez; Philippe Delagrange; Jean-Pierre Galizzi; E Jacoby; Jean-Paul Volland; Daniel Lesieur; Pierre Renard; Emmanuel Canet; Jean-Luc Fauchère; Jean A Boutin
Substrate specificity and inhibition studies of human serotonin N-acetyltransferase.
The Journal of biological chemistry 2000;275(12):8794-805.
2000: Jean A Boutin; Chantal Lahaye; C Pegurier; Jean-Paul Nicolas; JL Fauchere; M Langlois; Pierre Renard; Philippe Delagrange; Emmanuel Canet
Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries.
Journal of receptor and signal transduction research 2000;20(1):105-18.
1999: Francis Cogé; S P Guenin; A Renouard-Try; Herve RIQUE; C Ouvry; N Fabry; Philippe Beauverger; Jean-Paul Nicolas; Jean-Pierre Galizzi; Jean A Boutin; Emmanuel Canet
Truncated isoforms inhibit [3H]prazosin binding and cellular trafficking of native human alpha1A-adrenoceptors.
The Biochemical journal 1999;343 Pt 1():231-9.
1999: P Paul; Chantal Lahaye; Philippe Delagrange; Jean-Paul Nicolas; Emmanuel Canet; Jean A Boutin
Characterization of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organs.
The Journal of pharmacology and experimental therapeutics 1999;290(1):334-40.
1999: A Acín; Marianne Rodriguez; Herve RIQUE; Emmanuel Canet; Jean A Boutin; Jean-Pierre Galizzi
Cloning and characterization of the 5' flanking region of the human uncoupling protein 3 (UCP3) gene.
Biochemical and biophysical research communications 1999;258(2):278-83.
1999: Jean A Boutin; W Marande; L Petit; Armelle Loynel; C Desmet; Emmanuel Canet; Jean-Luc Fauchère
Investigation of S-farnesyl transferase substrate specificity with combinatorial tetrapeptide libraries.
Cellular signalling 1999;11(1):59-69.
1998: Michel Félétou; Marianne Rodriguez; Philippe Beauverger; M Germain; Jérôme Imbert; Sandra Dromaint; Christelle Macia; A Bourrienne; JM Henlin; Jean-Paul Nicolas; Jean A Boutin; Jean-Pierre Galizzi; Jean-Luc Fauchère; Emmanuel Canet; Jacques Duhault
NPY receptor subtypes involved in the contraction of the proximal colon of the rat.
Regulatory peptides 1998;75-76():221-9.
1998: Jean A Boutin; W Marande; M Goussard; Armelle Loynel; Emmanuel Canet; JL Fauchere
Chromatographic assay and peptide substrate characterization of partially purified farnesyl- and geranylgeranyltransferases from rat brain cytosol.
Archives of biochemistry and biophysics 1998;354(1):83-94.
1997: V Girard; Michel Félétou; Charles Advenier; Emmanuel Canet
Effects of tachykinins and capsaicin on the mechanical and electrical activity of the guinea-pig isolated trachea.
British journal of pharmacology 1997;122(5):841-8.
1997: B Portevin; Michel Lonchampt; Emmanuel Canet; Guillaume De Nanteuil
Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives.
Journal of medicinal chemistry 1997;40(12):1906-18.
1997: Anne Roussin; Véronique Le Cabec; Michel Lonchampt; J De Nadaï; Emmanuel Canet; Isabelle Maridonneau-Parini
Neutrophil-associated inflammatory responses in rats are inhibited by phenylarsine oxide.
European journal of pharmacology 1997;322(1):91-6.
1997: Gilles Ferry; Michel Lonchampt; L Pennel; Guillaume De Nanteuil; Emmanuel Canet; Gordon C Tucker
Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury.
FEBS letters 1997;402(2-3):111-5.
1996: C Corriu; Michel Félétou; Emmanuel Canet; Paul M Vanhoutte
Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig.
British journal of pharmacology 1996;119(5):959-64.
1996: P Robineau; A Dhainaut; Emmanuel Canet
An almitrine analog acts as hypoxia in isolated rat lungs.
Respiration physiology 1996;105(3):225-33.
1996: L Foissier; Michel Lonchampt; F Cogé; Emmanuel Canet
In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor.
The Journal of pharmacology and experimental therapeutics 1996;278(3):1484-90.
1996: J Bonnet; N Kucharczyk; P Robineau; Michel Lonchampt; C Dacquet; D Regoli; Jean-Luc Fauchère; Emmanuel Canet
A water-soluble, stable dipeptide NK1 receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects: S18523.
European journal of pharmacology 1996;310(1):37-46.
1996: Michel Félétou; E Bonnardel; Emmanuel Canet
Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide.
British journal of pharmacology 1996;118(6):1371-6.
1996: C Thurieau; Michel Félétou; P Hennig; E Raimbaud; Emmanuel Canet; Jean-Luc Fauchère
Design and synthesis of new linear and cyclic bradykinin antagonists.
Journal of medicinal chemistry 1996;39(10):2095-101.
1996: Michel Félétou; I Jamonneau; M Germain; C Thurieau; Jean-Luc Fauchère; P Villa; P Ghezzi; Emmanuel Canet
Bradykinin B2 receptor involvement in rabbit and murine models of septic shock.
Journal of cardiovascular pharmacology 1996;27(4):500-7.
1996: C Corriu; Michel Félétou; Emmanuel Canet; Paul M Vanhoutte
Inhibitors of the cytochrome P450-mono-oxygenase and endothelium-dependent hyperpolarizations in the guinea-pig isolated carotid artery.
British journal of pharmacology 1996;117(4):607-10.
1996: C A Martin; Michel Félétou; Michel Lonchampt; C Dacquet; A Dhainaut; Emmanuel Canet
In vitro pharmacological effects of S 12370 (2-[4-benzhydryloxypiperidinoethyl]isoxindole; an antibronchoconstrictor agent) in normal and sensitized tissue.
Fundamental & clinical pharmacology 1996;10(5):458-66.
1995: P Robineau; Michel Lonchampt; N Kucharczyk; J E Krause; D Regoli; J L Fauchere; J F Prost; Emmanuel Canet
In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist.
European journal of pharmacology 1995;294(2-3):677-84.
1995: Michel Félétou; Michel Lonchampt; P Robineau; I Jamonneau; C Thurieau; Jean-Luc Fauchère; P Villa; P Ghezzi; J F Prost; Emmanuel Canet
Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
The Journal of pharmacology and experimental therapeutics 1995;273(3):1078-84.
1995: Michel Félétou; V Girard; Emmanuel Canet
Different involvement of nitric oxide in endothelium-dependent relaxation of porcine pulmonary artery and vein: influence of hypoxia.
Journal of cardiovascular pharmacology 1995;25(4):665-73.
1995: Michel Félétou; C A Martin; mathieu molimard; Emmanuel Naline; M Germain; C Thurieau; Jean-Luc Fauchère; Emmanuel Canet; Charles Advenier
In vitro effects of HOE 140 in human bronchial and vascular tissue.
European journal of pharmacology 1995;274(1-3):57-64.
1994: Michel Félétou; M Germain; C Thurieau; Jean-Luc Fauchère; Emmanuel Canet
Agonistic and antagonistic properties of the bradykinin B2 receptor antagonist, Hoe 140, in isolated blood vessels from different species.
British journal of pharmacology 1994;112(2):683-9.
1993: N Kucharczyk; C Thurieau; J Paladino; A D Morris; J Bonnet; Emmanuel Canet; J E Krause; D Regoli; R Couture; Jean-Luc Fauchère
Tetrapeptide tachykinin antagonists: synthesis and modulation of the physicochemical and pharmacological properties of a new series of partially cyclic analogs.
Journal of medicinal chemistry 1993;36(11):1654-61.